Aidan King is Managing Partner and co-founder of Fountain Healthcare Partners. Aidan qualified as a pharmacist from Trinity College Dublin and in 1992 joined Elan Corporation’s strategic marketing group with the responsibility of identifying and evaluating product development candidates for Elan’s drug delivery technologies. In 1996, Aidan assumed. Head of Strategic Marketing for Elan’s drug delivery division with a focus on competitive analysis and strategic positioning of Elan's technology platforms.. Having completed an MBA at University College Dublin in 1998, Aidan moved to the U.S. as one of the founding members of Elan’s corporate venture capital group. Over the next five years, Aidan undertook twenty-two strategic investments in public and private specialty pharma, biotechnology and medical device companies, in the U.S., Canada and Europe. Investments included Quadrant Healthcare (acquired by Elan, 2000), Atrix laboratories (acquired by QLT, 2004), Idun Pharmaceuticals (acquired by Pfizer, 2005) and Zealand Pharmaceuticals (IPO, 2010).. In 2004, Aidan joined Bio-IB, a New York based boutique life science investment bank where he was responsible for M&A and strategic licensing transactions. Aidan is a CFA charter holder and sits on the boards of Civitas Therapeutics and Palyon Medical.
